Stock 4746 FORMOSA LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Formosa Laboratories, Inc.

Equities

4746

TW0004746003

Pharmaceuticals

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
101 TWD -0.98% Intraday chart for Formosa Laboratories, Inc. +2.33% -0.98%
Mar. 12 Formosa Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 07 Japanese Shares Close Lower But Hit Fresh 52-Week High on US Rate Cut Assurance MT

Business Summary

Formosa Laboratories, Inc. is a Taiwan-based company principally engaged in the development, production and distribution of ultraviolet (UV)-proof active ingredients, bulk pharmaceutical chemicals, antibody drug conjugates, as well as the provision of customized services. The Company primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The Company distributes its products to Europe, the Americas, Asia and other markets.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Active Pharmaceutical Ingredient
99.3 %
3,764 100.0 % 4,329 99.3 % +15.01%
Other
0.7 %
1 0.0 % 31 0.7 % +2,270.49%

Sales per region

TWD in Million2022Weight2023Weight Delta
India
23.6 %
919 24.4 % 1,031 23.6 % +12.23%
Others
20.7 %
614 16.3 % 903 20.7 % +47.22%
Netherlands
13.2 %
378 10.0 % 577 13.2 % +52.78%
Japan
7.2 %
229 6.1 % 312 7.2 % +36.38%
Germany
7.0 %
231 6.1 % 307 7.0 % +32.76%
Taiwan
6.4 %
381 10.1 % 278 6.4 % -26.92%
China
6.3 %
220 5.8 % 273 6.3 % +23.88%
Switzerland
6.2 %
280 7.4 % 272 6.2 % -2.96%
United States
6.2 %
190 5.1 % 269 6.2 % +41.49%
Canada
3.2 %
209 5.5 % 138 3.2 % -33.81%

Managers

Managers TitleAgeSince
Cheng Yue Cheng CEO
 Chief Executive Officer - 95-12-28
Yue Chen Lo DFI
 Director of Finance/CFO - 03-04-13
Chin Yuan Lin IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Ting Kai Wu BRD
 Director/Board Member 86 10-05-10
Charles Lin BRD
 Director/Board Member - 16-06-27
Cheng Yue Cheng CEO
 Chief Executive Officer - 95-12-28
Pei Wei Fang BRD
 Director/Board Member - 06-08-09
Che Jen Chuang BRD
 Director/Board Member - 12-06-17
Lue Chieh Wang BRD
 Director/Board Member - 08-07-16
Hung Min Hsieh BRD
 Director/Board Member - 06-08-27
Wen Ying Yu BRD
 Director/Board Member - 10-05-10
Chih Han Chung BRD
 Director/Board Member - 08-07-16
Ting Jung Chang BRD
 Director/Board Member - 16-11-09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 120,256,000 100,705,963 ( 83.74 %) 0 83.74 %

Shareholders

NameEquities%Valuation
Cathay Securities Investment Trust Co., Ltd.
4.580 %
5,508,003 4.580 % 19 M NT$
Mega International Investment Trust Co., Ltd.
1.572 %
1,890,587 1.572 % 6 M NT$
Capital Investment Trust Corp.
1.231 %
1,480,001 1.231 % 5 M NT$
Dimensional Fund Advisors Ltd.
0.1042 %
125,366 0.1042 % 421 106 NT$
DWS Far Eastern Investments Ltd.
0.0504 %
60,644 0.0504 % 203 704 NT$
DFA Australia Ltd.
0.0225 %
27,036 0.0225 % 90 814 NT$

Holdings

NameEquities%Valuation
EIRGENIX INC.
6.11%
 18,702,818 6.11% 50,842,676 $

Company contact information

Formosa Laboratories, Inc.

No. 36 Hoping Street Louchu County

338 02, Taoyuan

+

http://www.formosalab.com
address Formosa Laboratories, Inc.(4746)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Formosa Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
101 TWD
Average target price
137.5 TWD
Spread / Average Target
+36.14%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
FORMOSA LABORATORIES, INC. Stock Formosa Laboratories, Inc.
-0.98% 372M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.25% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+28.59% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.55% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.16% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.36% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.81% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-3.69% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4746 Stock
  4. Company Formosa Laboratories, Inc.